The healthcare company has posted a loss in the wake of a failed stock offer.

The Public Investment Corporation, South Africa’s biggest stock investor, says local ownership is key for growing the economy and empowering people.

The drawn-out battle for Adcock now sees CFR’s offer for Adcock now facing resistance from the PIC, which says the offer is not up to scratch.

A day after putting in an offer to acquire part of Adcock Ingram, Bidvest is taking the company to court over an "unlawful" guarantee.

Drugmaker Adcock Ingram says the $1.2-billion takeover bid from CFR Pharmaceuticals is still the best option, despite Bidvest’s offer.

A Chilean group’s $1.2-billion bid for Adcock Ingram has been challenged by a court action from Bidvest.

Bidvest has put in a R4-billion offer for pharmaceuticals company Adcock, countering that of Chilean company CFR Pharmaceuticals.

Chile’s largest drugmaker will decide within weeks whether to make a binding offer for Adcock Ingram Holdings.

Adcock Ingram has entered into discussions with a Chile-based firm, which could see SA benefit from a possible combined revenue of R12.1-billion.